March 23, 2009 - CircuLite Inc.
March 23, 2009 - Pathway Medical Technologies Inc. today said the FDA granted the company 510(k) clearance to market the Jetstream G2 specifically for use in breaking apart and removing thrombus (or blood clots) from the upper and lower extremity peripheral arteries.
March 23, 2009 - FiatLux Imaging and Panasonic Computer Solutions Co. will demonstrate at HIMSS 2009 the advanced visualization capabilities of FiatLux Visualize optimized for the next generation of tablet computers for the healthcare industry including the new the Panasonic Toughbook H1 Mobile Clinical Assistant (MCA).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
During TCT 2009 this past fall in Washington D.C. I had the chance to listen to Shigeru Saito, M.D., FACC, ShonanKamakura General Hospital, Sapporo, Japan, explain reasons why he feels transradial artery access for interventional procedures is better than the U.S. standard of femoral access. Dr.
March 20, 2009 - Stanford University School of Medicine researchers have pooled three years of individual patient data to compare the effectiveness of coronary artery bypass surgery versus angioplasty on specific groups of patients.
March 20, 2009 - Stanford University School of Medicine researchers have pooled three years of individual patient data to compare the effectiveness of coronary artery bypass surgery versus angioplasty on specific groups of patients.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 20, 2009 - Endologix Inc. yesterday announced the first presentation of initial outcomes with up to two-year patient follow-up from its Powerlink Suprarenal Proximal Extension trial; the Powerlink System is for the minimally invasive treatment of abdominal aortic aneurysms (AAA).
March 19, 2009 – The enrollment phase of the RAFT clinical trial (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial) is complete, announced Medtronic Inc.
March 20, 2009 – MEDRAD Inc. Multi Vendor Service has launched TotalRepair, reportedly the first and only guaranteed repair solution on select ultrasound probes. Enabled by 100 percent repair capabilities, TotalRepair aims to allow healthcare facilities to spend less on costly exchanges and replacements by maximizing the use of probe repair.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 20, 2009 - ARCA biopharma Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, said today two Gencaro (bucindolol hydrochloride) abstracts will be presented as poster sessions at the American College of Cardiology 58th Annual Scientific Session March 29-31, 2009 in Orlando, FL.
March 19, 2009 - The ZOLL Medical Corp. LifeVest Wearable Defibrillator has been prescribed for patients by physicians at all of the “Honor Roll” hospitals designated by U.S. News and World Report.
March 20, 2009 - Cook Inc. said yesterday it will promptly appeal an initial ruling by the District Court of Düsseldorf, Germany denying the company’s claim that Edwards Lifesciences is infringing Cook’s German patent for transcatheter valve technology.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 20, 2009 – Siemens Healthcare subsidiary PETNET Solutions is opening a new SPECT radiopharmacy in Raleigh, NC. Through an agreement with Covidien Medical Imaging, PETNET now offers a combined portfolio of high energy and low energy radioisotopes to the nuclear medicine community, further expanding its PET and SPECT coverage.
March 20 ,2009 - One of the current controversies in the field of adult congenital heart disease is whether patients should be cared for at an adult or pediatric facility and by an adult or pediatric heart surgeon, and a new study published in the March issue of the Annals of Thoracic Surgery evaluates this issue.
March 20, 2009 - BRAHMS AG of Hennigsdorf, Germany and Annapolis, MD, recently submitted a 510(k) file to the FDA to market its patented BRAHMS MR-proANP Kryptor Test used to find biomarkers for heart failure.